GH
Common StockGuardant Health, Inc.
Reported Shares
67.5K
Position Mix
No options reported
Reported Value
$12.0M
Portfolio Weight
7.87%
Reported 13F portfolio for Q3 2026.
Reported 13F Portfolio Value
$153.0M
Data Refreshed
Nov 17, 2026
Portfolio Structure
Company profiles & logos by Twelve Data
GH
Common StockGuardant Health, Inc.
Reported Shares
67.5K
Position Mix
No options reported
Reported Value
$12.0M
Portfolio Weight
7.87%
TGTX
Common StockTG THERAPEUTICS, INC.
Reported Shares
187.7K
Position Mix
No options reported
Reported Value
$10.5M
Portfolio Weight
6.84%
ABVX
Depositary ReceiptAbivax S.A.
Reported Shares
90.9K
Position Mix
No options reported
Reported Value
$9.0M
Portfolio Weight
5.88%
PRAX
Common StockPraxis Precision Medicines, Inc.
Reported Shares
29.7K
Position Mix
No options reported
Reported Value
$8.6M
Portfolio Weight
5.65%
COGT
Common StockCogent Biosciences, Inc.
Reported Shares
210.5K
Position Mix
No options reported
Reported Value
$6.7M
Portfolio Weight
4.41%
LLY
Common StockELI LILLY & Co
Reported Shares
5.5K
Position Mix
No options reported
Reported Value
$6.4M
Portfolio Weight
4.15%
NTRA
Common StockNatera, Inc.
Reported Shares
13.8K
Position Mix
No options reported
Reported Value
$5.7M
Portfolio Weight
3.73%
VERA
Common StockVera Therapeutics, Inc.
Reported Shares
159.6K
Position Mix
No options reported
Reported Value
$5.2M
Portfolio Weight
3.37%
VKTX
Common StockViking Therapeutics, Inc.
Reported Shares
147.5K
Position Mix
No options reported
Reported Value
$4.8M
Portfolio Weight
3.14%
IONS
Common StockIONIS PHARMACEUTICALS INC
Reported Shares
107K
Position Mix
No options reported
Reported Value
$4.8M
Portfolio Weight
3.12%
ELVN
Common StockEnliven Therapeutics, Inc.
Reported Shares
100.2K
Position Mix
No options reported
Reported Value
$4.6M
Portfolio Weight
3.00%
CAI
Common StockCaris Life Sciences, Inc.
Reported Shares
146.1K
Position Mix
No options reported
Reported Value
$4.5M
Portfolio Weight
2.92%
NKTR
Common StockNEKTAR THERAPEUTICS
Reported Shares
73.7K
Position Mix
No options reported
Reported Value
$4.5M
Portfolio Weight
2.92%
CYTK
Common StockCYTOKINETICS INC
Reported Shares
60.1K
Position Mix
No options reported
Reported Value
$4.0M
Portfolio Weight
2.59%
VSTM
Common StockVerastem, Inc.
Reported Shares
429K
Position Mix
No options reported
Reported Value
$3.5M
Portfolio Weight
2.26%
MAZE
Common StockMaze Therapeutics, Inc.
Reported Shares
114.7K
Position Mix
No options reported
Reported Value
$3.1M
Portfolio Weight
2.04%
RYTM
Common StockRHYTHM PHARMACEUTICALS, INC.
Reported Shares
32.2K
Position Mix
No options reported
Reported Value
$3.1M
Portfolio Weight
2.00%
TXG
Common Stock10x Genomics, Inc.
Reported Shares
30.1K
Position Mix
No options reported
Reported Value
$2.7M
Portfolio Weight
1.78%
ALKS
Common StockAlkermes plc.
Reported Shares
61.3K
Position Mix
No options reported
Reported Value
$2.5M
Portfolio Weight
1.62%
UTHR
Common StockUNITED THERAPEUTICS Corp
Reported Shares
4.1K
Position Mix
No options reported
Reported Value
$2.2M
Portfolio Weight
1.46%